bimol. cyclic peptide ;; (6708-06-1)

Other Product

• bimol. cyclic 1,2-ethanediyl ester ;;
• Bradykinin, bimol. (9®1')-peptide (9CI)
• AZASERINE, CYCLIC PEPTIDE (TRANS)
• AZASERINE, CYCLIC PEPTIDE (CIS)
• Annosquamosin A (cyclic peptide)
• 6-(8-hydroxyoctyl)-bimol. cyclic ester ;;
• 1,4,7,10,13-Pentaazacyclohexadecane, cyclic peptide deriv.
• Kallidin, cyclic (10®2)-peptide (9CI)
• Pentanoic acid,5-(â-D-glucopyranosyloxy)-4- oxo-,cyclic 1f6'-bimol. ester
• Somatostatin (sheep),8-D-tryptophan-,cyclic (14f1)-peptide
• 4-18-Atrial natriuretic peptide-21 (human reduced),N-(8-amino-1-oxooctyl)-,cyclic (18f4)-peptide
• Neuropeptide F 1(Locusta migratoria reduced), bimol. cyclic (1®6'),(6®1')-bis(disulfide) (9CI)
• Glycine,N-(2-pyrrolidinylmethyl)glycyl-D-phenylalanyl-L-prolyl-, cyclic (4®1)-peptide, (S)- (9CI)
• Glycine,L-tyrosyl-D-lysyl-L-tryptophyl-, cyclic (4®2)-peptide (9CI)
• Bradykinin,1-L-lysine-6-glycine-, cyclic (9®1)-peptide (9CI)
• L-Alanine,D-glutaminyl-(3S)-3-hydroxy-LR- glutamyl-N-methyl-L-valyl-,cyclic (2f1)-peptide
• 9,18-(Iminoethaniminoethaniminoethaniminomethano)pyrrolo(1,2:8,9)(1,5,8,11,14)thiatetraazacyclooctadecino(18,17-b)indole, cyclic peptide deriv.
• L-Valine,N-9-acridinyl-D-seryl-L-alanyl-L-cysteinyl-, bimol. (4®1'),(4'®1)-dilactone, cyclic (3®3')-disulfide (9CI)
• L-Valine,N-(2-quinoxalinylcarbonyl)-L-seryl-L-alanyl-L-cysteinyl-, bimol. (4®1'),(4'®1)-dilactone, cyclic (3®3')-disulfide (9CI)
• b-D-Glucopyranose, cyclic4,6-[(1S)-4-(6-carboxy-2,3,4-trihydroxyphenoxy)-4',5,5',6,6'-pentahydroxy[1,1'-biphenyl]-2,2'-dicarboxylate]1,3-bis(3,4,5-trihydroxybenzoate), bimol. cyclic ester (9CI)